logo VRX

Resources

Guidelines
Resources
MTX Monitoring Tool
Expert Discussions
Clinical Articles

Guidelines

Consensus Guidelines

<em>Consensus Guideline for Use of Glucarpidase in Patients with High‐Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance.</em>

Read More

Highlights - Consensus Guidelines

Highlighted excerpts from the <em>Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance.</em>

Download PDF

Glucarpidase Treatment Algorithm

Download and print for your practice: Treatment algorithm based on the Consensus Guidelines.

Download PDF

Stocking Guidelines

Review the stocking guidelines established by an international expert panel.

Read More

NCCN Guidelines

Review the National Comprehensive Cancer Network Guidelines for treating various cancers.

Read More

Resources

Early Warning Signs

Download this resource to help you identify the early warning signs for methotrexate toxicity.

Download PDF

Voraxaze® 5-Minute Educational Video

Watch and learn about the importance of identifying HDMTX toxicity and when to use Voraxaze<sup>&reg;</sup>.

Watch Video
<div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"> <div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><iframe allow="autoplay; fullscreen" allowfullscreen="" allowtransparency="true" class="wistia_embed" frameborder="0" height="100%" msallowfullscreen="" name="wistia_embed" scrolling="no" src="https://fast.wistia.net/embed/iframe/8xt5d30a2l?videoFoam=true" title="Voraxaze_NurseHuddle-FINAL_100220 Video" width="100%"></iframe></div> </div> <script src="https://fast.wistia.net/assets/external/E-v1.js" async type="text/javascript"></script>

MTX Monitoring Tool

Methotrexate Monitoring Tool

Visit MTXPK.org to see if your patient is clearing MTX as expected. This tool was independently developed by Dr. Laura Ramsey of Cincinnati Children&rsquo;s Medical Center and lead author of the Consensus Guidelines<sup>5</sup> and provides:<br /> &nbsp; <ul> <li>A free, open-access clinical decision-making tool for monitoring plasma MTX elimination in both adult and pediatric patients</li> <li>No log in required</li> <li>No patient data stored on the website (but can be stored to local computer and browser)</li> <li>Visual display of data shows expected and actual MTX elimination curves along with serum creatinine trend and predicted time to reach discharge threshold levels</li> <li>Patient report can be downloaded and saved as PDFs or printed</li> </ul>

Read More

MTXPK Tutorial Video

MTXPK Tutorial Video

Watch Video
<div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"> <div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><iframe allow="autoplay; fullscreen" allowfullscreen="" allowtransparency="true" class="wistia_embed" frameborder="0" height="100%" msallowfullscreen="" name="wistia_embed" scrolling="no" src="https://fast.wistia.net/embed/iframe/hbdpu1ff5i?videoFoam=true" title="MTXPK-Shoot-Final_update Video" width="100%"></iframe></div> </div> <script src="https://fast.wistia.net/assets/external/E-v1.js" async type="text/javascript"></script>

Expert Discussions

OncLive® Webinar

Watch leading experts discuss the current landscape of high-dose methotrexate toxicity and treatment options to improve patient outcomes.

Watch Now

<em>The ASCO® Post</em> CME

Review a roundtable discussion between 3 experts about how to identify patients treated with HDMTX who are at risk for developing AKI, the clinical implications of guidelines, and strategies to integrate guidelines into practice.

Watch Now

Consensus Guideline Expert Interview

Watch and listen to experts discuss important information about guidelines for managing patients with delayed methotrexate elimination due to renal impairment.

Watch Video
<div class="wistia_responsive_padding" style="padding:56.25% 0 0 0;position:relative;"> <div class="wistia_responsive_wrapper" style="height:100%;left:0;position:absolute;top:0;width:100%;"><iframe allowfullscreen="" allowtransparency="true" class="wistia_embed" frameborder="0" height="100%" mozallowfullscreen="" msallowfullscreen="" name="wistia_embed" oallowfullscreen="" scrolling="no" src="https://fast.wistia.net/embed/iframe/ot0rnkfkdk?videoFoam=true" title="Wistia video player" webkitallowfullscreen="" width="100%"></iframe></div> </div> <script src="https://fast.wistia.net/assets/external/E-v1.js" async type="text/javascript"></script>

JADPRO CE

Review the management of delayed MTX elimination due to AKI according to published clinical guidelines using two certified case-based activities of HDMTX toxicity created for oncology advanced practitioners.<br /> &nbsp;

Read More

Clinical Articles

<em>Length of stay, mortality, and readmissions among Medicare cancer patients treated with glucarpidase and conventional care: a retrospective study.

Examine hospital length of stay, mortality, and readmission rates for Medicare cancer patients with delayed clearance of MTX treated with glucarpidase.

Read More

<em>MTXPK.org</em>

A Clinical Decision Support Tool Evaluating High‐Dose Methotrexate Pharmacokinetics to Inform Post‐Infusion Care and Use of Glucarpidase.

Read More